CORESTATE appoints Dr. Kai G. Klinger as new head of Investor Relations
CORESTATE Capital Holding S.A. (CORESTATE), a fully integrated investment manager and co-investor based in Luxembourg, a…
CORESTATE Capital Holding S.A. (CORESTATE), a fully integrated investment manager and co-investor based in Luxembourg, a…
Ulf Mark Schneider, CEO of Fresenius, said: "2014 was a challenging but successful year for Fresenius. We made significa…
H1/2014: - Sales €10.7 billion (+7% at actual rates, +12% in constant currency) - EBIT[1] €1,403 million (-3% at act…
Fresenius today has sold its 5% stake in Rhön-Klinikum AG. Berenberg has acquired the approximately 6.9 million shares w…
Fresenius Helios has completed the acquisition of HSK Dr. Horst Schmidt Kliniken in Wiesbaden after receiving municipal…
. Q1/2014: - Sales €5.2 billion (+7% at actual rates, +11% in constant currency) - EBIT[1] €643 million (-8% at a…
Fresenius Helios has completed the acquisition of 38 hospitals and 11 outpatient facilities from Rhön-Klinikum AG. For t…
Fresenius Helios is moving to meet the conditions set by the German antitrust authority for the acquisition of 40 hospit…
Fresenius Helios will join Rhön-Klinikum AG in defending against the lawsuit filed by B. Braun Melsungen AG on November…
Red Hat, Inc, (NYSE: RHT), the world's leading provider of open source solutions, announced today the release of Red Hat…